Showing results (11-20 of 87) with videos related to
Sort By:
Pageof 9
Journal of Medicinal Chemistry|March 31, 2015
Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C AgentsSona Kovackova, Lei Chang, Elena Bekerman, et al.Methods in Molecular Biology (Clifton, N.J.)|June 29, 2019
Screening of Interactions with the ESCRT Machinery by a Gaussia princeps Split Luciferase-Based Complementation AssayRina Barouch-Bentov, Yves Jacob, Shirit EinavCellular and Molecular Life Sciences : CMLS|July 26, 2018
Viral journeys on the intracellular highwaysMakeda Robinson, Stanford Schor, Rina Barouch-Bentov, et al.Journal of Virology|September 29, 2004
A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replicationShirit Einav, Menashe Elazar, Tsafi Danieli, et al.The Journal of Infectious Diseases|May 22, 2010
The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitorsShirit Einav, Hadas D Sobol, Elizabeth Gehrig, et al.Viruses|September 27, 2025
The Use of Nonhuman Primate Models for Advancing HIV PrEPElena Bekerman, Christian CallebautJournal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Complement C4 is protective for lupus disease independent of C3Shirit Einav, Olga O Pozdnyakova, Minghe Ma, et al.Molecules (Basel, Switzerland)|December 10, 2021
Optimization of 4-Anilinoquinolines as Dengue Virus InhibitorsPei-Tzu Huang, Sirle Saul, Shirit Einav, et al.Bioorganic & Medicinal Chemistry Letters|October 8, 2021
Identification and evaluation of 4-anilinoquin(az)olines as potent inhibitors of both dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV)Sirle Saul, Pei-Tzu Huang, Shirit Einav, et al.STAR Protocols|February 24, 2024
Chemical inactivation strategies for SARS-CoV-2-infected cells and organoidsMarwah Karim, Amol Arunrao Pohane, Chieh-Wen Lo, et al.Pageof 9